Correlation between Plasminogen Activator Inhibitor-1 (PAI-1) and Infarct Size in Acute Myocardial Infarction

Respiration and Circulation

Volumn 46, Issue 5, 1998, Pages 483-487

  Soeki, Takeshi ^a   Tamura, Yoshiyuki ^b   Takeichi, Naoki ^b   Shinohara, Hisanori ^b   Yui, Yasuko ^b   Fukuda, Nobuo ^b   Sui, Osamu ^a  

^a National Hospital Organization   (Japan)

^b NONE

Author keywords

Acute myocardial infarction; Plasminogen activator inhibitor 1; Thallium 201 myocardial imaging

Indexed keywords

ACUTE PHASE PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR; THALLIUM 201;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; FIBRINOLYSIS; HEART INFARCTION SIZE; HUMAN; MALE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0031979660     PISSN: 04523458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Barbash GI, Hod H, Roth A, et al : Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction. Am J Cardiol 64 : 1231-1235, 1989
2. Sakamoto T, Yasue H, Ogawa H, et al : Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction. Am J Cardiol 70 : 271-276, 1992
3. Honda Y, Oshima S, Ogawa H, et al : Plasma lipoprotein (a) levels and fibrinolytic activity in acute myocardial infarction. Jpn Circ J 58 : 869-876, 1991
4. Hamsten A, Wiman B, Faire UD, Blomback M . Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction N Engl J Med 313 : 1557-1563, 1985
5. Loskutoff DJ, Sawdey M, Mimuro J : Type l plasminogen activator inhibitor. Prog Hemost Thromb 9 : 87-115, 1989
6. Haverkate F, Thompson SG, Duckert F : Haemostasis factors in angina pectoris : relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group. Thromb Haemost 73 : 561-567, 1995
7. Pedersen OD, Gram J, Jespersen J : Plasminogen activator inhibitor type-1 determines plasmin formation in patients with ischaemic heart disease. Thromb Haemost 73 : 835-840, 1995
8. Masuda T, Yasue H, Ogawa H, et al : Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina. Am Heart J 124 : 314-319, 1992
9. Kruithof EK, Gudinchet A, Bachmann F. Plasminogen activator inhibitor 1 and plasminogen activator inhibitor 2 in various disease states Thrombosis & Haemostasis 59 : 7-12, 1988
10. Chandler WL, Stratton JR : Laboratory evaluation of fibrinolysis in patients with a history of myocardial infarction. Am J Clin Pathol 102 : 248-252, 1994
11. Juhan-Vague I, Pyke SDM, Alessi MC, et al : on behalf of the ECAT Study Group : Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 94 : 2057-2063, 1996
12. Tamaki S, Nakajima H, Murakami T, et al : Estimation of infarct size by myocardial emission computed tomography with thallium-201 and its relation to creatine kinase-MB release after myocardial infarction in man. Circulation 66 : 994-1001, 1982
13. Vatncr SF, Baig H, Manders WT, Maroko PR : Effects of coronary artery reperfusion on myocardial infarct size calculated from creatine kinase. J Clin Invest 61 : 1048-1056, 1978
14. Pennica D, Holmes WE, Kohr WJ, et al : Cloning and expression of human tissue-type plasminogen activator cDNA in E coli. Nature 301 : 214-221, 1983